| COVID-19 and cancer: a comprehensive review R Gosain, Y Abdou, A Singh, N Rana, I Puzanov, MS Ernstoff Current oncology reports 22, 1-15, 2020 | 349 | 2020 |
| Primary and secondary breast angiosarcoma: single center report and a meta-analysis Y Abdou, A Elkhanany, K Attwood, W Ji, K Takabe, M Opyrchal Breast Cancer Research and Treatment 178, 523-533, 2019 | 71 | 2019 |
| Immunotherapy in triple negative breast cancer: beyond checkpoint inhibitors Y Abdou, A Goudarzi, JX Yu, S Upadhaya, B Vincent, LA Carey NPJ Breast Cancer 8 (1), 121, 2022 | 39 | 2022 |
| Racial differences in CD8+ T cell infiltration in breast tumors from Black and White women Y Abdou, K Attwood, TYD Cheng, S Yao, EV Bandera, GR Zirpoli, ... Breast Cancer Research 22, 1-10, 2020 | 39 | 2020 |
| Mechanism‐based treatment of cancer with immune checkpoint inhibitor therapies Y Abdou, M Pandey, M Sarma, S Shah, J Baron, MS Ernstoff British journal of clinical pharmacology 86 (9), 1690-1702, 2020 | 33 | 2020 |
| Left sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancer Y Abdou, M Gupta, M Asaoka, K Attwood, O Mateusz, S Gandhi, K Takabe Scientific Reports 12 (1), 13377, 2022 | 26 | 2022 |
| Pregnancy after breast cancer in young BRCA carriers: an international hospital-based cohort study M Lambertini, E Blondeaux, E Agostinetto, AS Hamy, HJ Kim, A Di Meglio, ... JAMA 331 (1), 49-59, 2024 | 21 | 2024 |
| Mucous membrane pemphigoid causing central airway obstruction BA Jalil, YG Abdou, SA Rosen, T Dammad Journal of Bronchology & Interventional Pulmonology 24 (4), 334-338, 2017 | 18 | 2017 |
| A phase 1, first-in-human (FIH) study of the anti-HER2 CAR macrophage CT-0508 in subjects with HER2 overexpressing solid tumors. KA Reiss, Y Yuan, NT Ueno, ML Johnson, S Gill, EC Dees, J Chao, ... Journal of Clinical Oncology 40 (16_suppl), 2533-2533, 2022 | 14 | 2022 |
| Newly approved and emerging agents in HER2-positive metastatic breast cancer SL Graff, F Yan, Y Abdou Clinical breast cancer 23 (7), e380-e393, 2023 | 12 | 2023 |
| The landscape of immune microenvironments in racially diverse breast cancer patients AM Hamilton, AN Hurson, LT Olsson, A Walens, J Nsonwu-Farley, EL Kirk, ... Cancer Epidemiology, Biomarkers & Prevention 31 (7), 1341-1350, 2022 | 10 | 2022 |
| Combination of pembrolizumab and imatinib in a patient with double KIT mutant melanoma: a case report Y Abdou, A Kapoor, L Hamad, MS Ernstoff Medicine 98 (44), e17769, 2019 | 9 | 2019 |
| A phase II single‐arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability … ZM Nakamura, AM Deal, EM Park, KE Stanton, YE Lopez, LJ Quillen, ... Cancer Medicine 12 (7), 8172-8183, 2023 | 7 | 2023 |
| The evolving landscape of immune checkpoint inhibitors and antibody drug conjugates in the treatment of early-stage breast cancer PV Bhardwaj, YG Abdou The Oncologist 28 (10), 832-844, 2023 | 6 | 2023 |
| A phase 1, first-in-human (FIH) study of adenovirally transduced autologous macrophages engineered to contain an anti-HER2 chimeric antigen receptor (CAR) in participants with … KA Reiss, Y Yuan, NT Ueno, ML Johnson, S Gill, EC Dees, J Chao, ... Journal of Clinical Oncology 40 (16_suppl), TPS2677-TPS2677, 2022 | 6 | 2022 |
| External validation of the COmorbidity test N Villalobos, R Davidson, UK Ghori, Y Abdou, J Abukhalaf, RV Guillamet COPD: Journal of Chronic Obstructive Pulmonary Disease 14 (5), 513-517, 2017 | 5 | 2017 |
| PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone … EL Mayer, Y Ren, N Wagle, R Mahtani, C Ma, A DeMichele, M Cristofanilli, ... Journal of Clinical Oncology 42 (17), 2050-2060, 2024 | 4 | 2024 |
| Abstract GS1-01: race and clinical outcomes in the RxPONDER Trial (SWOG S1007) Y Abdou, WE Barlow, JR Gralow, F Meric-Bernstam, KS Albain, DF Hayes, ... Cancer Research 83 (5_Supplement), GS1-01-GS1-01, 2023 | 4 | 2023 |
| machine learning-assisted prognostication based on genomic expression in the tumour microenvironment of estrogen receptor positive and her2 negative breast cancer Y Abdou, A Baird, J Dolan, S Lee, S Park Annals of Oncology 30, v55-v56, 2019 | 4 | 2019 |
| Abstract OT2-06-02: chemokine modulation to enhance the effectiveness of pembrolizumab in patients with metastatic triple negative breast cancer Y Abdou, LE Williams, P Kalinski, M Opyrchal Cancer Research 79 (4_Supplement), OT2-06-02-OT2-06-02, 2019 | 4 | 2019 |
